Genitourinary Cancer
News
Most Targeted Cancer Drugs Lack Substantial Clinical Benefit
Researchers assess validity of the molecular targets and clinical benefits of genome-targeted cancer drugs approved in the United States from 2015...
Latest News
Meat Linked to Higher Erectile Dysfunction Risk
NYU urologist discusses impact of a plant-based diet on heart health, prostate cancer, and sexual health.
Conference Coverage
How New ICI Combos Change Bladder Cancer Management
Immune checkpoint inhibitor combinations have restructured treatment guidelines for metastatic urothelial carcinoma.
Conference Coverage
No Routine Cancer Screening Option? New MCED Tests May Help
CanScan, MERCURY, and OncoSeek can detect a range of cancers and recognize the tissue of origin with high accuracy.
News
Oncologists Voice Ethical Concerns Over AI in Cancer Care
Researchers ask 204 oncologists from 37 states for their views on the ethical implications of using AI for cancer care.
Conference Coverage
Repeat MCED Testing May ID Early-Stage and Unscreened Cancers
Eight of 26 patients with cancer signals detected through MCED had cancer.
News
Less Than 50% of Accelerated Approvals Show Clinical Benefit
Researchers review 46 cancer drugs granted accelerated approvals between 2013 and 2017.
News
New Trials in Prostate Cancer: Could Your Patient Benefit?
Two new trials for patients with metastatic castration-resistant prostate cancer that involve remaining on therapy until disease progression...
News
Virtual Reality Brings Relief to Hospitalized Patients With Cancer
Patients were randomized to receive either 10 minutes of immersive VR distraction therapy or 10 minutes of two-dimensional guided imagery...
News
Prostate Cancer Tsunami Coming, Experts Caution
Expert suggests approaches for enabling earlier diagnosis of prostate cancer in men in low- to middle-income countries.
